塞栓療法は、様々な病状を治療するために、塞栓剤を使用して血管や血流を遮断する低侵襲な医療処置です。塞栓剤は、固体粒子、ゲル、または液体で、血管に直接注入され、血管を凝固させ、身体の特定の部位に血液が流れるのを妨げます。塞栓療法は、子宮筋腫、肝腫瘍、動脈瘤、血管奇形など、さまざまな疾患の治療に使用されます。この技術は従来の手術よりも低侵襲で、外来で行うことができることもあり、回復に要する時間も短く、合併症も少ないとされています。市場成長の主な要因は、低侵襲手術の需要の高まり、低侵襲手術に対する有利な償還シナリオ、塞栓療法機器の技術進歩の高まりです。
低侵襲手術に対する需要の高まりは、塞栓療法市場の成長をサポートすると予想されます。塞栓療法は、がん、子宮筋腫、動脈瘤、血管奇形など、さまざまな病状を治療するために用いられる低侵襲な処置です。Statistaによると、2019年、世界の低侵襲手術市場は205億米ドルとなり、2030年には440億4,000万米ドルに達すると予測されています。その結果、低侵襲手術に対する需要の高まりが、市場の成長を促進すると予想されます。また、新興国市場の患者数の増加や、医療・ヘルスケア施設整備のための政府・民間団体による資金調達や投資の増加は、予測期間中に同市場に有利な機会をもたらすと予想されています。しかし、十分なエビデンスの欠如と不利な規制シナリオ、代替療法の強い市場ポジショニングが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。
世界の塞栓療法市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。北アメリカは、主要な市場プレイヤーの存在、有利な償還政策、市場開拓のための投資の増加により、最大の市場シェアを占めています。一方、アジア太平洋地域は、医療観光の活発化、医療ネットワークの開拓、研究開発活動の活発化などの要因により、予測期間中に最も急速に成長すると予想され、アジア太平洋地域の塞栓療法市場にとって有利な成長見通しを生み出すと考えられます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Embolotherapy Market, by region, 2019-2029 (USD Billion)
1.2.2. Embolotherapy Market, by Product, 2019-2029 (USD Billion)
1.2.3. Embolotherapy Market, by Procedure, 2019-2029 (USD Billion)
1.2.4. Embolotherapy Market, by Disease indication, 2019-2029 (USD Billion)
1.2.5. Embolotherapy Market, by End user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Embolotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Embolotherapy Market Dynamics
3.1. Embolotherapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising demand for the minimally invasive surgical procedures
3.1.1.2. Favourable reimbursement scenario for minimally invasive surgeries
3.1.1.3. Growing technological advancements in embolotherapy devices
3.1.2. Market Challenges
3.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
3.1.2.2. Strong market positioning of alternative therapies
3.1.3. Market Opportunities
3.1.3.1. Growing target patient populations
3.1.3.2. Rising funding & investment by government and private organizations
Chapter 4. Global Embolotherapy Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Embolotherapy Market, by Product
6.1. Market Snapshot
6.2. Global Embolotherapy Market by Product, Performance - Potential Analysis
6.3. Global Embolotherapy Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Embolotherapy Market, Sub Segment Analysis
6.4.1. Embolic Agents
6.4.2. Support Devices
Chapter 7. Global Embolotherapy Market, by Procedure
7.1. Market Snapshot
7.2. Global Embolotherapy Market by Procedure, Performance - Potential Analysis
7.3. Global Embolotherapy Market Estimates & Forecasts by Procedure 2019-2029 (USD Billion)
7.4. Embolotherapy Market, Sub Segment Analysis
7.4.1. Transcatheter Arterial Embolization (TAE)
7.4.2. Selective Internal Radiation Therapy (SIRT)
7.4.3. Trans arterial Chemoembolization (TACE)
Chapter 8. Global Embolotherapy Market, by Disease indication
8.1. Market Snapshot
8.2. Global Embolotherapy Market by Disease indication, Performance - Potential Analysis
8.3. Global Embolotherapy Market Estimates & Forecasts by Disease indication 2019-2029 (USD Billion)
8.4. Embolotherapy Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Peripheral Vascular Disease
8.4.3. Neurological Diseases
8.4.4. Urological
8.4.5. Nephrological Disorders
8.4.6. Gastrointestinal Disorders
Chapter 9. Global Embolotherapy Market, by End user
9.1. Market Snapshot
9.2. Global Embolotherapy Market by End user, Performance - Potential Analysis
9.3. Global Embolotherapy Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
9.4. Embolotherapy Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgery Centers
9.4.4. Others
Chapter 10. Global Embolotherapy Market, Regional Analysis
10.1. Embolotherapy Market, Regional Market Snapshot
10.2. North America Embolotherapy Market
10.2.1. U.S. Embolotherapy Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
10.2.1.2. Procedure breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. End user breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Embolotherapy Market
10.3. Europe Embolotherapy Market Snapshot
10.3.1. U.K. Embolotherapy Market
10.3.2. Germany Embolotherapy Market
10.3.3. France Embolotherapy Market
10.3.4. Spain Embolotherapy Market
10.3.5. Italy Embolotherapy Market
10.3.6. Rest of Europe Embolotherapy Market
10.4. Asia-Pacific Embolotherapy Market Snapshot
10.4.1. China Embolotherapy Market
10.4.2. India Embolotherapy Market
10.4.3. Japan Embolotherapy Market
10.4.4. Australia Embolotherapy Market
10.4.5. South Korea Embolotherapy Market
10.4.6. Rest of Asia Pacific Embolotherapy Market
10.5. Latin America Embolotherapy Market Snapshot
10.5.1. Brazil Embolotherapy Market
10.5.2. Mexico Embolotherapy Market
10.5.3. Rest of Latin America Embolotherapy Market
10.6. Rest of The World Embolotherapy Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Imbiotechnologies Ltd.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Johnson & Johnson
11.2.3. Kaneka Corporation
11.2.4. Medtronic Plc
11.2.5. Meril Life Sciences Pvt. Ltd.
11.2.6. Merit Medical Systems, Inc.
11.2.7. Penumbra, Inc.
11.2.8. Simbionix USA Corporation
11.2.9. Sirtex Medical Limited
11.2.10. Stryker Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Embolotherapy Market, report scope
TABLE 2. Global Embolotherapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Embolotherapy Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Embolotherapy Market estimates & forecasts by Procedure 2019-2029 (USD Billion)
TABLE 5. Global Embolotherapy Market estimates & forecasts by Disease indication 2019-2029 (USD Billion)
TABLE 6. Global Embolotherapy Market estimates & forecasts by End user 2019-2029 (USD Billion)
TABLE 7. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Embolotherapy Market
TABLE 72. List of primary sources, used in the study of global Embolotherapy Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Embolotherapy Market, research methodology
FIG 2. Global Embolotherapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Embolotherapy Market, key trends 2021
FIG 5. Global Embolotherapy Market, growth prospects 2022-2029
FIG 6. Global Embolotherapy Market, porters 5 force model
FIG 7. Global Embolotherapy Market, pest analysis
FIG 8. Global Embolotherapy Market, value chain analysis
FIG 9. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Embolotherapy Market, regional snapshot 2019 & 2029
FIG 15. North America Embolotherapy Market 2019 & 2029 (USD Billion)
FIG 16. Europe Embolotherapy Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Embolotherapy Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Embolotherapy Market 2019 & 2029 (USD Billion)
FIG 19. Global Embolotherapy Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
Description
Global Embolotherapy Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Embolotherapy is a minimally invasive medical procedure that involves the use of embolic agents to block blood vessels or blood flow in order to treat a variety of medical conditions. Embolic agents can be solid particles, gels, or liquids that are injected directly into a blood vessel, causing the vessel to clot and preventing blood from flowing to a specific area of the body. Embolotherapy is used to treat a variety of conditions, including uterine fibroids, liver tumors, aneurysms, and vascular malformations. The technique is minimally invasive than traditional surgery and can be performed on an outpatient basis in some cases, with shorter recovery times and fewer complications. The key factor driving the market growth is rising demand for the minimally invasive surgical procedures, favorable reimbursement scenario for minimally invasive surgeries and growing technological advancement in embolotherapy devices.
The rising demand for minimally invasive surgical procedures is anticipated to support the growth of the embolotherapy market. Embolotherapy is a minimally invasive technique used to treat a wide range of medical conditions, including cancer, uterine fibroids, aneurysms, and vascular malformations. According to Statista, in 2019, the minimally invasive surgery market globally was valued USD 20.5 billion and it is anticipated to reach USD 44.04 billion by 2030. As a result, the rising demand for the minimally invasive surgical procedures is anticipated to propel the market growth. Additionally, the growing target patient population and rising funding & investment by government and private organizations for the medical and health care facility development is anticipated to create the lucrative opportunity for the market during projected period. However, the lack of sufficient evidence & unfavorable regulatory scenario, and strong market positioning of alternative therapies stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Embolotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market holding the largest market share, owing to the presence of key market players, favorable reimbursement policies, and growing investments for the healthcare facility development. Whereas, Asia Pacific is anticipated to exhibit fastest growing region during forecasted period over the forecast period, owing to factors such as booming medical tourism, developing healthcare network and increasing research and development activities in the region would create lucrative growth prospects for the Embolotherapy market across Asia Pacific region.
Major market players included in this report are:
Imbiotechnologies Ltd.
Johnson & Johnson
Kaneka Corporation
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Merit Medical Systems, Inc.
Penumbra, Inc.
Simbionix USA Corporation
Sirtex Medical Limited
Stryker Corporation
Recent Developments in the Market:
In 2021, Terumo Corporation has received FDA approval for the PMA Supplement for the WEB 17 System, a novel component of the WEB Aneurysm Embolisation System for the treatment of intracranial wide-neck bifurcation aneurysms.
Global Embolotherapy Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Procedure, Disease indication, End user, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Product:
Embolic Agents
Support Devices
By Procedure:
Transcatheter Arterial Embolization (TAE)
Selective Internal Radiation Therapy (SIRT)
Trans arterial Chemoembolization (TACE)
By Disease indication:
Cancer
Peripheral Vascular Disease
Neurological Diseases
Urological
Nephrological Disorders
Gastrointestinal Disorders
By End user:
Hospitals
Clinics
Ambulatory Surgery Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Table of Contents
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Embolotherapy Market, by region, 2019-2029 (USD Billion)
1.2.2. Embolotherapy Market, by Product, 2019-2029 (USD Billion)
1.2.3. Embolotherapy Market, by Procedure, 2019-2029 (USD Billion)
1.2.4. Embolotherapy Market, by Disease indication, 2019-2029 (USD Billion)
1.2.5. Embolotherapy Market, by End user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Embolotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Embolotherapy Market Dynamics
3.1. Embolotherapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising demand for the minimally invasive surgical procedures
3.1.1.2. Favourable reimbursement scenario for minimally invasive surgeries
3.1.1.3. Growing technological advancements in embolotherapy devices
3.1.2. Market Challenges
3.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
3.1.2.2. Strong market positioning of alternative therapies
3.1.3. Market Opportunities
3.1.3.1. Growing target patient populations
3.1.3.2. Rising funding & investment by government and private organizations
Chapter 4. Global Embolotherapy Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Embolotherapy Market, by Product
6.1. Market Snapshot
6.2. Global Embolotherapy Market by Product, Performance - Potential Analysis
6.3. Global Embolotherapy Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Embolotherapy Market, Sub Segment Analysis
6.4.1. Embolic Agents
6.4.2. Support Devices
Chapter 7. Global Embolotherapy Market, by Procedure
7.1. Market Snapshot
7.2. Global Embolotherapy Market by Procedure, Performance - Potential Analysis
7.3. Global Embolotherapy Market Estimates & Forecasts by Procedure 2019-2029 (USD Billion)
7.4. Embolotherapy Market, Sub Segment Analysis
7.4.1. Transcatheter Arterial Embolization (TAE)
7.4.2. Selective Internal Radiation Therapy (SIRT)
7.4.3. Trans arterial Chemoembolization (TACE)
Chapter 8. Global Embolotherapy Market, by Disease indication
8.1. Market Snapshot
8.2. Global Embolotherapy Market by Disease indication, Performance - Potential Analysis
8.3. Global Embolotherapy Market Estimates & Forecasts by Disease indication 2019-2029 (USD Billion)
8.4. Embolotherapy Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Peripheral Vascular Disease
8.4.3. Neurological Diseases
8.4.4. Urological
8.4.5. Nephrological Disorders
8.4.6. Gastrointestinal Disorders
Chapter 9. Global Embolotherapy Market, by End user
9.1. Market Snapshot
9.2. Global Embolotherapy Market by End user, Performance - Potential Analysis
9.3. Global Embolotherapy Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
9.4. Embolotherapy Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgery Centers
9.4.4. Others
Chapter 10. Global Embolotherapy Market, Regional Analysis
10.1. Embolotherapy Market, Regional Market Snapshot
10.2. North America Embolotherapy Market
10.2.1. U.S. Embolotherapy Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
10.2.1.2. Procedure breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. End user breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Embolotherapy Market
10.3. Europe Embolotherapy Market Snapshot
10.3.1. U.K. Embolotherapy Market
10.3.2. Germany Embolotherapy Market
10.3.3. France Embolotherapy Market
10.3.4. Spain Embolotherapy Market
10.3.5. Italy Embolotherapy Market
10.3.6. Rest of Europe Embolotherapy Market
10.4. Asia-Pacific Embolotherapy Market Snapshot
10.4.1. China Embolotherapy Market
10.4.2. India Embolotherapy Market
10.4.3. Japan Embolotherapy Market
10.4.4. Australia Embolotherapy Market
10.4.5. South Korea Embolotherapy Market
10.4.6. Rest of Asia Pacific Embolotherapy Market
10.5. Latin America Embolotherapy Market Snapshot
10.5.1. Brazil Embolotherapy Market
10.5.2. Mexico Embolotherapy Market
10.5.3. Rest of Latin America Embolotherapy Market
10.6. Rest of The World Embolotherapy Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Imbiotechnologies Ltd.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Johnson & Johnson
11.2.3. Kaneka Corporation
11.2.4. Medtronic Plc
11.2.5. Meril Life Sciences Pvt. Ltd.
11.2.6. Merit Medical Systems, Inc.
11.2.7. Penumbra, Inc.
11.2.8. Simbionix USA Corporation
11.2.9. Sirtex Medical Limited
11.2.10. Stryker Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
